Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)
We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25.